The FutureSoup,
I respectfully disagree with some of your points.
I can't see how we would get such a paltry sum for both AH and the VMC. Perhaps with McRae and his unique ability to always exact the bare minimum (or even less) I would think we would see less than a standard multiple on the AH business, but now with a guy like Gubitz on the BoD, one can expect that those days are gone. So even if you only get 3x rev for AH you're at $90+ mil....throw in VMC and you get upwards of the $110-120M.
I doubt we will see the 0.70c that Rube calculated, but I still don't think that 0.35-0.5c is out of the question. Remember that Wells also sees a direct benefit in all of this and I have to think that 10c won't do.
I also think that when the company has rid itself of all of McRae's failed pipe dreams (aka burn), the market will treat us more favourably. Probably higher than the 0.5c you claim, possibly closer to a buck. That will then become our stay point until a partner is signed, HC approves Urocidin or we get sold off.....what effect any of those will have is anyones guess.
Either way, I think we may (for a long welcome change) be positively surprised...rose coloured glasses maybe, but the anchor known as McRae has been thrown overboard and with that dead weight gone, we'll finally behave like a normal company....